Phagocytic activity of neutrophil is induced by granulocyte colony stimulating factor and interleukin-15 in leukemic animal model

Pierson, 1997, The role of autologous natural killer cells in chronic myelogenous leukemia, Leuk Lymph, 27, 387, 10.3109/10428199709058306 Druckrey, 1966, Teratogenic and carcinogenic effects in the offspring after single injection of ethylnitrosourea to pregnant rats, Nature, 210, 1378, 10.1038/2101378a0 Yamashiro, 2001, Phenotypic and functional change of cytokine-activated neutrophils: inflammatory neutrophils are heterogeneous and enhance adaptive immune responses, J Leukoc Biol, 69, 698, 10.1189/jlb.69.5.698 Jacobs, 2010, Subclinical responses in healthy cyclists briefly exposed to traffic-related air pollution: an intervention study, Environ Health, 9, 64, 10.1186/1476-069X-9-64 Waugh, 2008, The interleukin-8 pathway in cancer, Clin Cancer Res, 14, 6735, 10.1158/1078-0432.CCR-07-4843 Silver, 1957, The role of the mature neutrophil in bacterial infections in acute leukemia, Blood, 12, 814, 10.1182/blood.V12.9.814.814 De Larco, 2004, The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8, Clin Cancer Res, 10, 4895, 10.1158/1078-0432.CCR-03-0760 Balasubramanian, 2002, Protein kinase C isoforms in normal and leukemic neutrophils: altered levels in leukemic neutrophils and changes during myeloid maturation in chronic myeloid leukemia, Leuk Res, 26, 67, 10.1016/S0145-2126(01)00098-4 Akira, 2006, Pathogen recognition and innate immunity, Cell, 124, 783, 10.1016/j.cell.2006.02.015 Underhill, 2002, Toll-like receptors: key mediators of microbe detection, Curr Opin Immunol, 14, 103, 10.1016/S0952-7915(01)00304-1 Hollingshead, 1991, Recombinant granulocyte colony stimulating factor(rG-CSF): a review of its pharmacological properties and prospective role in neutropenic conditions, Drugs, 42, 300, 10.2165/00003495-199142020-00009 Hariss, 1994, Bone marrow changes associated with recombinant granulocyte- macrophage and granulocyte colony stimulating factors: discrimination of granulocytic regeneration, Arch pathol lab Med, 118, 624 Rapoport, 1992, Granulocyte- macrophage colony stimulating factor (GM-CSF) and granulocyte colony stimulating factor (G-CSF); receptor biology, signal transduction and neutrophil activation, Blood Rev, 6, 43, 10.1016/0268-960X(92)90007-D Wan, 2015, Effect of granulocyte-macrophage colony-stimulating factor on prevention and treatment of invasive fungal disease in recipients of allogeneic stem-cell transplantation: a prospective multicenter randomized phase IV Trial, J Clin Oncol, 33, 3999, 10.1200/JCO.2014.60.5121 Adachi, 1994, In vitro administration of granulocyte colony stimulating factor promotes neutrophil survival in vitro, Eur J Haematol, 53, 129, 10.1111/j.1600-0609.1994.tb00660.x Girard, 1996, Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: modulation of phagocytosis, cytoskeleton rearrangement, gene expression and apoptosis by IL-15, Blood, 88, 3176, 10.1182/blood.V88.8.3176.bloodjournal8883176 Musso, 1998, Interleukin-15 activates proinflammatory and antimicrobial functions in polymorphonuclear cells, Infect Immun, 66, 2640, 10.1128/IAI.66.6.2640-2647.1998 Jablonska, 2001, Effect of IL-15 on the secretion of IL-1beta, IL-1Ra and sIL-1RII by neutrophils from cancer patients, Cytokine, 16, 173, 10.1006/cyto.2001.0931 Alonso-Lebrero, 2000, Polarization and interaction of adhesion molecules P-selectin glycoprotein ligand 1 and intercellular adhesion molecule 3 with moesin and ezrin in myeloid cells, Blood, 95, 2413, 10.1182/blood.V95.7.2413 Ratthé, 2004, Interleukin-15 enhances human neutrophil phagocytosis by a Syk-dependent mechanism: importance of the IL-15R alpha chain, J Leukoc Biol, 76, 162, 10.1189/jlb.0605298 Bhattacharjee, 2015, Role of G-CSF plus IL-15 on neutrophil population in peripheral blood modulating protein tyrosine kinase activity in leukemic mouse, Int J Curr Res, 04, 15180 Berger, 2009, Safety and immunologic effects of IL-15 administration in nonhuman primates, Blood, 114, 2417, 10.1182/blood-2008-12-189266 Gascon, 2010, Development of a new G-CSF product based on biosimilarity assessment, Ann Oncol, 21, 1419, 10.1093/annonc/mdp574 Boxio, 2004, Mouse bone marrow contains large numbers of functionally competent neutrophils, J Leukoc Biol, 75, 604, 10.1189/jlb.0703340 Law, 2003, Role of biomodulators and involvement of protein tyrosine kinase on stem cell migrate on in normal and leukaemic mice, Immunol Lett, 86, 287, 10.1016/S0165-2478(03)00028-2 Hayashi, 2003, Toll-like receptors stimulate human neutrophil function, Blood, 102, 2660, 10.1182/blood-2003-04-1078 Alyssa, 2011, Tumor-Associated neutrophils: new targets for cancer therapy, Cancer Res, 71, 2411, 10.1158/0008-5472.CAN-10-2583 Justice, 1999, Mouse ENU mutagenesis, Hum Mol Genet, 8, 1955, 10.1093/hmg/8.10.1955 Dexter, 1974, Studies on the mechanisms of chemical leukaemogenesis, Br J Cancer, 30, 325, 10.1038/bjc.1974.200 Briançon-Marjollet, 2010, NG2-expressing glial precursor cells are a new potential oligodendroglioma cell initiating population in N-ethyl- N-nitrosourea-induced gliomagenesis, Carcinogenesis, 31, 1718, 10.1093/carcin/bgq154 Stoica, 2002, ENU-induced ovarian cancer, Methods Mol biology™, 188, 305 Chatterjee, 2009, Kinetic impairment of haemopoietic stem cells in experimentally induced leukemia and aplastic anemia: an inverse correlation, J stem cells, 4, 179 Singha, 2015, Cytotoxic activity of T lymphocytes is induced upon stimulation with IL-3 plus GM-CSF in animal leukemia model, Leuk Res, 10.1016/j.leukres.2015.08.011 Chen, 2011, Increased expression of miR-34a in mouse spleen one day after exposure to N-ethyl-N-nitrosourea, J Appl Toxicol, 31, 496, 10.1002/jat.1640 Vaquero, 1998, Immune-cell system provides the development of extraneural tumors in the ethyl-nitrosourea model of neurocarcinogenesis, Cancer Lett, 123, 95, 10.1016/S0304-3835(97)00420-5 O'Mahony, 2008, Differential constitutive and cytokine-modulated expression of human toll-like receptors in primary neutrophils, monocytes, and macrophages, Int J Med Sci, 5, 1, 10.7150/ijms.5.1 Fridlender, 2009, Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN, Cancer Cell, 16, 183, 10.1016/j.ccr.2009.06.017 Colombo, 1992, Granulocyte colony-stimulating factor (G-CSF) gene transduction in murine adenocarcinoma drives neutrophil-mediated tumor inhibition in vivo. Neutrophils discriminate between G-CSF producing and G-CSF nonproducing tumor cells, J Immunol, 149, 113, 10.4049/jimmunol.149.1.113 Kandasamy, 2011, Lactobacilli secreting a tumor antigen and IL15 activates neutrophils and dendritic cells and generates cytotoxic T lymphocytes against cancer cells, Cell Immunol, 271, 89, 10.1016/j.cellimm.2011.06.004 Demetri, 1991, Granulocyte colony-stimulating factor and its receptor, Blood, 78, 2791, 10.1182/blood.V78.11.2791.bloodjournal78112791 Stier, 2013, Combinations of TLR ligands: a promising approach in cancer immunotherapy, Clin Dev Immunol, 14